Old Mission Capital LLC Abb Vie Inc. Transaction History

Old Mission Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $337,031 - $428,477	-2,449 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $323,219 - $401,023	2,449 New	2,449 $397,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $283,064 - $311,619	-2,767 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $237,712 - $278,996	2,767 New	2,767 $242,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $287,890 - $320,043	-3,238 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $290,707 - $343,972	3,238 New	3,238 $300,000

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.